The global digital pathology association market size is expected to reach USD 2,234.9 Million in 2030 and register a revenue CAGR of 13.2% over the forecast period, according to the latest report by Reports and Data. Increasing incidence of cancer and growing application of digital pathology association in drug development and companion diagnostics is driving digital pathology association market revenue growth.
In a digital environment, digital pathology association entails the capture, management, exchange, and interpretation of pathology information, such as slides and data. When glass slides are scanned with a scanning instrument, a high-resolution digital image is produced, that may be viewed on a computer screen or mobile device. Rise in prevalence of cardiovascular diseases is the driving force behind the development of new diagnostic solutions. Increase in frequency of chronic and cardiovascular diseases rises leads to a rise in demand for digital pathology association systems, driving digital pathology association market growth forward.
Rise in demand for accurate diagnoses as well as increased investment in development of innovative digital pathology association systems by different companies, is driving global digital pathology association market revenue growth. Chronic illnesses have been linked to a higher death rate. As the frequency of chronic and cardiovascular illnesses rise, so does the need for digital pathology association systems, driving digital pathology association market revenue growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1493
Some Key Factors Contributing to the Global Pharma Healthcare Market Growth
Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.
Some Key Highlights From the Report
- On 2nd September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio. The alliance will address the unmet requirements of pathology laboratories throughout the world, based on a shared vision of end-to-end quality and standardization of tissue diagnostics. The firms' common objective is to develop technology, products, and services that will improve pathology lab uniformity and speed up to correct diagnosis.
- Scanner segment accounted for largest revenue share in 2021. Cloud-enabled digital pathology association scanners offer the most flexibility for storing, archiving, and managing digital pictures and metadata which in turn is driving revenue growth of the segment.
- Human pathology segment accounted for largest revenue share in 2021. digital pathology association allows for more accurate analysis. It includes methods for automatic slide analysis that are objective, quick, and precise. It also gives scientists fast access to previously linked instances, serves as information storage for long-term predictive analytics, and it helps doctors to detect major diseases such as tumors more efficiently and accurately.
- Drug discovery segment accounted for largest revenue share in 2021. Drug development improvements in digital pathology association are enhancing the therapy possibilities for a number of disorders. With greater time and data, gathering, analyzing, and sharing information becomes easier, resulting in more effective, high-quality, focused research all over the world driving the segment revenue growth.
- Hospital segment accounted for largest revenue share in 2021 as a result of the huge number of medical procedures and operations performed in hospitals. Most hospitals have accessibility to well-defined organ databases, which could be used to verify the supply of requested organs, allowing for quicker medical action which is driving revenue growth of the segment.
- Market in North America accounted for the largest revenue share in 2021. Development and innovation in digital pathology association products and presence of several biotechnologies and medical product industries, as well as advanced healthcare facilities, are driving revenue growth of the digital pathology association market in this region.
Top Players in the Global digital pathology association Market:
Leica Biosystems Nussloch GmbH, Hamamatsu Photonics K.K., F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., XIFIN, Inc., Huron Technologies International Inc., Visiopharm A/S, Aiforia Technologies, and Akoya Biosciences, Inc.
The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.
To know more about the report @ https://www.reportsanddata.com/report-detail/digital-pathology-market
digital pathology association Market Segmentation:
Product Outlook (Revenue, USD Billion; 2019–2030)
- Scanners
- Software
- Storage Solution
Type Outlook (Revenue, USD Billion; 2019–2030)
- Human Pathology
- Veterinary Pathology
Application Outlook (Revenue, USD Billion; 2019–2030)
- Drug Discovery
- Disease Diagnosis
- Training Education
End-use Outlook (Revenue, USD Billion; 2019–2030)
- Academic Research Institutes
- Hospitals Reference Laboratories
- Pharmaceutical Biotechnology Companies
Global digital pathology association Market Report: Regional Segmentation
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1493
Frequently Asked Questions Answered in the Report:
- What is the estimated revenue growth rate of the global digital pathology association market over the forecast period?
- What are the major factors driving the global market revenue growth?
- Which are the leading manufacturers and suppliers in the global digital pathology association market?
- Which regional market is expected to lead in terms of revenue share in the global digital pathology association market over the forecast years?
- What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Read More Reports:
Cognitive Assessment and Training in Healthcare Market: https://www.reportsanddata.com/report-detail/cognitive-assessment-and-training-in-healthcare-market
Hemostasis Analyzers Market: https://www.reportsanddata.com/report-detail/hemostasis-analyzers-market
Health Information Systems Market: https://www.reportsanddata.com/report-detail/health-information-systems-market
Organ Perfusion System Market: https://www.reportsanddata.com/report-detail/organ-perfusion-system-market
Respiratory Syncytial Virus Diagnostic Market: https://www.reportsanddata.com/report-detail/respiratory-syncytial-virus-diagnostic-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
